MARKET

MTEM

MTEM

Molecular Templates Inc
NASDAQ
2.240
-0.120
-5.08%
After Hours: 2.260 +0.02 +0.89% 19:23 03/28 EDT
OPEN
2.780
PREV CLOSE
2.360
HIGH
2.780
LOW
2.100
VOLUME
378.40K
TURNOVER
0
52 WEEK HIGH
9.45
52 WEEK LOW
1.680
MARKET CAP
12.04M
P/E (TTM)
-0.3348
1D
5D
1M
3M
1Y
5Y
Molecular Templates announces $9.5M private placement offering
Molecular Templates, Inc. +21.18% premarket to $2.86. Molecular Templates announces $9.5M private placement offering. MTEM intends to use the net proceeds to fund its ongoing clinical studies, working capital and for general corporate purposes.
Seeking Alpha · 22h ago
Molecular Templates Inc Raises Funds for Clinical Studies
Molecular Templates, Inc. (MTEM) has engaged in a private placement with institutional and accredited investors. The company is raising an initial $20 million through the sale of shares and warrants. The proceeds are earmarked for clinical studies, working capital, and general corporate purposes.
TipRanks · 23h ago
Molecular Templates Inc <MTEM.OQ> expected to post a loss of 97 cents a share - Earnings Preview
Molecular Templates Inc expected to report a 197.8% increase in quarterly revenue to $7.775 million. The company is expected to post a loss of 97 cents a share. The one available analyst rating on the shares is 'buy' for the company.
Reuters · 2d ago
12 Health Care Stocks Moving In Monday's Intraday Session
Landos Biopharma (NASDAQ:LABP) shares rose 173.9% to $21.45 during Monday's regular session. The company's, Q4 earnings report came out 2 days ago. Sagimet Biosciences ( NASDAQ:SGMT) and XTL Biopharmaceuticals also moved upwards. Trxade Health stock decreased by 48.6% during the regular session to $12.38.
Benzinga · 3d ago
Weekly Report: what happened at MTEM last week (0318-0322)?
Weekly Report · 4d ago
Top 5 Health Care Stocks Which Could Rescue Your Portfolio In March
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its weakness. Molecular Templates, Inc. Is one of the major oversold players in this sector.
Benzinga · 03/19 12:08
12 Health Care Stocks Moving In Monday's Intraday Session
Fresh2 Group (NASDAQ:FRES) shares rose 41.7% to $0.66 during Monday's regular session. Akso Health Group stock moved upwards by 29.0%. ChromaDex stock rose upwards by 27.91%. Trxade Health shares declined by 33.0% during the session.
Benzinga · 03/18 17:31
12 Health Care Stocks Moving In Monday's Pre-Market Session
Applied DNA Sciences (APDN) stock moved upwards by 33.1% to $0.49 during Monday's pre-market session. XTL Biopharmaceuticals (XTLB) shares increased by 19.31%. 2seventy bio (TSVT) shares rose 17.7%. Titan Pharma (TTNP) shares declined by 18.2% during the session.
Benzinga · 03/18 13:05
More
About MTEM
Molecular Templates, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery and development of targeted biologic therapeutics. Its drug platform technology, known as engineered toxin bodies (ETBs), leverages the resident biology of a genetically engineered form of Shiga-like Toxin A subunit to create novel therapies with potent and differentiated mechanisms of action for cancer. Its product pipeline includes MT-6402, MT-8421 and MT-0169. MT-6402 is an ETB consisting of a single chain variable fragment (scFv), with affinity for PD-L1, fused to the enzymatically active de-immunized Shiga-like toxin-A subunit (SLTA) and a class I antigen derived from the human cytomegalovirus (HCMV). pp65 protein. MT-8421, its ETB targeting CTLA-4, along with MT-6402. MT-0169 focuses on targeting CD38. CD38 is a single-chain type II transmembrane glycoprotein that is expressed by a variety of hematologic cells in an activation- and differentiation-dependent manner.

Webull offers Molecular Templates Inc stock information, including NASDAQ: MTEM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MTEM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MTEM stock methods without spending real money on the virtual paper trading platform.